DAWN Relative Valuation
DAWN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DAWN is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
Median5y
0.00
FCF Yield
Median3y
Median5y
People Also Watch
FAQ
Is Day One Biopharmaceuticals Inc (DAWN) currently overvalued or undervalued?
What is Day One Biopharmaceuticals Inc (DAWN) fair value?
How does DAWN's valuation metrics compare to the industry average?
What is the current P/B ratio for Day One Biopharmaceuticals Inc (DAWN) as of Apr 03 2025?
What is the current FCF Yield for Day One Biopharmaceuticals Inc (DAWN) as of Apr 03 2025?
What is the current Forward P/E ratio for Day One Biopharmaceuticals Inc (DAWN) as of Apr 03 2025?